APA (7th ed.) Citation

Santoro, A., Assenat, E., Yau, T., Delord, J., Maur, M., Knox, J., . . . Chan, S. L. (2024). A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma. JHEP reports, 6(4), . https://doi.org/10.1016/j.jhepr.2024.101021

Chicago Style (17th ed.) Citation

Santoro, Armando, et al. "A Phase Ib/II Trial of Capmatinib Plus Spartalizumab Vs. Spartalizumab Alone in Patients with Pretreated Hepatocellular Carcinoma." JHEP Reports 6, no. 4 (2024). https://doi.org/10.1016/j.jhepr.2024.101021.

MLA (9th ed.) Citation

Santoro, Armando, et al. "A Phase Ib/II Trial of Capmatinib Plus Spartalizumab Vs. Spartalizumab Alone in Patients with Pretreated Hepatocellular Carcinoma." JHEP Reports, vol. 6, no. 4, 2024, https://doi.org/10.1016/j.jhepr.2024.101021.